On CNBC's "Options Action," Mike Khouw said Moderna Inc MRNA looks to him a bit extended so he suggested an options strategy to make a bearish bet on the name.
To mitigate high options prices caused by high near-term implied volatility, Khouw wants to buy the October $240 put for $13.70 and sell the August $240 put for $5.90. The options structure would cost him $7.80 and he is hoping the stock is going to trade close to $240 at the August expiration.
Carter Worth gave his technical view on the stock. He said 17 analysts who cover the stock have an average price target of $187, while the stock is trading at $286.43. He has also noticed Moderna is trading at its internal trend line and he thinks it is time to harvest gains.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.